Genomic and Epigenomic Biomarkers of Toxicology and Disease
Clinical and Therapeutic Actions
Edited by
Saura C. Sahu
Formerly of Center for Food Safety and Applied Nutrition,US Food and Drug Administration,MD, USA
This edition first published 2022 © 2022 John Wiley & Sons Ltd
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of Saura C. Sahu to be identified as the author of the editorial material in this work has been asserted in accordance with law.
Registered Offices John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester PO19 8SQ, UK
Editorial Office The Atrium, Southern Gate, Chichester PO19 8SQ, UK
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Wiley also publishes its books in a variety of electronic formats and by print-on-demand. Some content that appears in standard print versions of this book may not be available in other formats.
Limit of Liability/Disclaimer of Warranty In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of experimental reagents, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each chemical, piece of equipment, reagent, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
A catalogue record for this book is available from the Library of Congress
Hardback ISBN: 9781119807674; ePub ISBN: 9781119807698; ePDF ISBN: 9781119807681;
Obook ISBN: 9781119807704
Cover image: © Ali Kahfi/Getty Images
Cover design by Wiley
Set in 9.5/12.5pt STIXTwoText by Integra Software Services Pvt. Ltd, Pondicherry, India
Contents
1 Cover
5 Preface
8 1 Genomic and Epigenomic Biomarkers for Predictive Toxicity and Disease
10 3 EV (Extracellular Vesicle)-associated miRNAs as Biomarkers of Toxicity
11 4 Circulating miRNAs as Biomarkers of Toxic Heavy Metal Exposure
12 5 MicroRNA Biomarkers of Malignant Mesothelioma
13 6 Role of Non-coding RNAs in Innate Immune Responses Perturbed by Environmental Arsenic Exposure
14 7 Transcriptomics: Applications in Toxicology and Medicine
15 8 Network Biology for Biomarker Discovery and Therapy in Cancer
16 9 Epigenetic Biomarkers: Link to Maternal Exposure and Offspring Health Outcomes
18 11 Emerging Non-invasive Molecular Biomarkers for Early Cancer Detection
19 12 Aberrant DNA Methylation of Tumor Suppressor Genes and Oncogenes as Cancer Biomarkers